WallStreetZenWallStreetZen

NASDAQ: CUE
Cue Biopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cue Biopharma earnings were -$40.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CUE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$9.5M, up 9.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CUE reported annual earnings of -$40.7M, with -19.8% growth. The next CUE earnings date is Jun 5, 2025.

CUE earnings history

Current Revenue
$9.3M
Current Earnings
-$40.7M
Current Profit Margin
-438%

CUE Return on Equity

Current Company
-172.1%
Current Industry
-2%
Current Market
34.1%
CUE's Return on Equity (-172.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CUE undefined

Current Company
-93.9%
Current Industry
-0.4%
CUE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CUE announces earnings.

CUE undefined

Current Company
-215.53%
Current Industry
5.9%
CUE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CUE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CUE-$37.53M-$40.67MN/A-$0.72
ICCC$540.61k-$2.16MN/A-$0.26
GANX-$19.79M-$20.41MN/A-$0.89
SKYE-$25.51M-$26.57MN/A-$0.73
PDSB-$36.30M-$37.61MN/A-$1.03
View Top Biotech Stocks

CUE earnings dates

Next earnings date
Jun 5, 2025

Cue Biopharma Earnings Reports & History FAQ

What were Cue Biopharma's earnings last quarter?

On CUE's earnings call on Invalid Date, Cue Biopharma (NASDAQ: CUE) reported Q4 2024 earnings per share (EPS) of -$0.10, up 65.52% year over year. Total CUE earnings for the quarter were -$9.50 million. In the same quarter last year, Cue Biopharma's earnings per share (EPS) was -$0.29.

If you're new to stock investing, here's how to buy Cue Biopharma stock.

When does Cue Biopharma report earnings?

The next CUE earnings call is Invalid Date. Add CUE to your watchlist to be reminded of Cue Biopharma's next earnings date.

Is Cue Biopharma profitable or losing money?

As of the last Cue Biopharma earnings report, Cue Biopharma is currently losing money. Cue Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$40.67 million, a 19.83% decrease year over year.

What was CUE's earnings growth in the past year?

As of Cue Biopharma's earnings date in Invalid Date, Cue Biopharma's earnings has grown year over year. CUE earnings in the past year totalled -$40.67 million.

What are Cue Biopharma's earnings expectations?

The current EPS estimate for Cue Biopharma's earnings report in Invalid Date is -$0.28.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.